Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Instil Bio, Inc. (TIL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/14/2023 |
8-K
| Quarterly results |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 04/28/2023 |
DEFR14A
| Form DEFR14A - Revised definitive proxy soliciting materials: |
| 04/24/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/24/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/24/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/14/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 03/31/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/31/2023 |
8-K
| Quarterly results |
| 03/10/2023 |
8-K
| Other Events Interactive Data |
| 02/27/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 02/14/2023 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in INSTIL BIO, INC. |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 9.5% stake in INSTIL BIO INC |
| 02/01/2023 |
8-K
| Quarterly results |
| 01/27/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
| 01/20/2023 |
4/A
| Crouch Bronson (CEO and Chairman) has filed a Form 4 on Instil Bio, Inc.|
Txns:
| Granted 750,000 options to buy
@ $8.62, valued at
$6.5M
|
|
| 01/20/2023 |
4/A
| Laumas Sandeep (CFO and CBO) has filed a Form 4 on Instil Bio, Inc.|
Txns:
| Granted 234,000 options to buy
@ $8.62, valued at
$2M
|
|
| 01/20/2023 |
4
| Crouch Bronson (CEO and Chairman) has filed a Form 4 on Instil Bio, Inc.|
Txns:
| Granted 1,000,000 options to buy
@ $0.634, valued at
$634k
|
|
| 01/20/2023 |
4
| Laumas Sandeep (CFO and CBO) has filed a Form 4 on Instil Bio, Inc.|
Txns:
| Granted 415,000 options to buy
@ $0.634, valued at
$263.1k
|
|
| 01/20/2023 |
4
| Ray Sumita (Chief Legal and Admin Officer) has filed a Form 4 on Instil Bio, Inc.|
Txns:
| Granted 415,000 options to buy
@ $0.634, valued at
$263.1k
Granted 50,000 options to buy
@ $0.7709, valued at
$38.5k
|
|
| 01/09/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 12/08/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/14/2022 |
8-K
| Quarterly results |
| 11/08/2022 |
8-K
| Quarterly results |
| 10/31/2022 |
8-K
| Quarterly results |
| 10/18/2022 |
8-K
| Quarterly results |
| 09/06/2022 |
4
| MOORE TIMOTHY L. (COO) has filed a Form 4 on Instil Bio, Inc.|
Txns:
| Granted 750,000 options to buy
@ $5.3, valued at
$4M
|
|
| 09/06/2022 |
3
| MOORE TIMOTHY L. (COO) has filed a Form 3 on Instil Bio, Inc. |
| 09/06/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/12/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/12/2022 |
8-K
| Quarterly results |
|
|
|